ÃØÃÜÑо¿Ëù

Thar Pharmaceuticals, Inc. is a clinical-stage, specialty pharmaceutical company that reinvents known, safe, on-the-market drugs by improving their clinical performance and economic benefits. The company focuses on transforming IV drugs into oral drugs for both the drug’s existing and new indications, and is quickly developing a pipeline of drug candidates using its proprietary technology platform. EnhanceTM Technology is a proprietary chemistry technology for solving clinical limitations such as bioavailability, safety, efficacy and stability. EnhanceTM Technology uses generally-recognized-as-safe (GRAS) compounds to improve drugs at the molecular level. These changes affect the drug’s physicochemical (solubility, permeability, melting point, etc.) and pharmacokinetic (bioavailability, onset, and absorption) properties. Although the pharmacokinetics of the drug are changed, neither the pharmacology nor the pharmacodynamics of the drug are changed.